Literature DB >> 18622157

Pathogenic agents in inflammatory bowel diseases.

Guillaume Pineton de Chambrun1, Jean-Frédéric Colombel, Daniel Poulain, Arlette Darfeuille-Michaud.   

Abstract

PURPOSE OF REVIEW: Infectious agents are still thought to be involved in the origin of inflammatory bowel disease. The focus in recent years has been more on Mycobacterium avium subsp paratuberculosis, adherent-invasive Escherichia coli or yeasts. RECENT
FINDINGS: A metaanalysis has shown a significant association of M. avium subsp paratuberculosis and Crohn's disease and a large randomized placebo-controlled trial reported an absence of sustained beneficial effects of combined antibiotic therapy on remission of active Crohn's disease. Adherent-invasive E. coli adhere via type 1 pili to carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6), abnormally expressed by intestinal epithelial cells in Crohn's disease patients. Both colonization of the ileal mucosa and stimulation of ileal epithelial cells by tumour necrosis factor-alpha induce overexpression of CEACAM6, leading to an amplification loop of colonization and inflammation. Anti-Saccharomyces cerevisiae mannan antibodies are the most prevalent serologic marker in Crohn's disease. Major oligomannose epitopes supporting antibody formation are expressed by Candida albicans in human tissues, suggesting that a loss of tolerance to C. albicans could lead to antibody formation in a subset of Crohn's disease patients who are genetically predisposed.
SUMMARY: M. avium subsp paratuberculosis, adherent-invasive E. coli and Candida are good candidates for an infectious aetiology of Crohn's disease on the basis of genetic susceptibility, which relates to impaired function in the defence against intracellular bacteria.

Entities:  

Mesh:

Year:  2008        PMID: 18622157     DOI: 10.1097/MOG.0b013e3283023be5

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  18 in total

Review 1.  Impact of the gut microbiome on mucosal inflammation.

Authors:  Warren Strober
Journal:  Trends Immunol       Date:  2013-08-16       Impact factor: 16.687

2.  Subversion of human intestinal mucosa innate immunity by a Crohn's disease-associated E. coli.

Authors:  A Jarry; L Crémet; N Caroff; C Bou-Hanna; J M Mussini; A Reynaud; A L Servin; J F Mosnier; V Liévin-Le Moal; C L Laboisse
Journal:  Mucosal Immunol       Date:  2014-10-01       Impact factor: 7.313

Review 3.  Oxygen metabolism and innate immune responses in the gut.

Authors:  Sean P Colgan; Eric L Campbell
Journal:  J Appl Physiol (1985)       Date:  2017-07-13

Review 4.  Etiology of Crohn's disease: many roads lead to autophagy.

Authors:  Pierre Lapaquette; Patrick Brest; Paul Hofman; Arlette Darfeuille-Michaud
Journal:  J Mol Med (Berl)       Date:  2012-07-14       Impact factor: 4.599

5.  Escherichia coli B2 Phylogenetic Subgroups in the Infant Gut Microbiota: Predominance of Uropathogenic Lineages in Swedish Infants and Enteropathogenic Lineages in Pakistani Infants.

Authors:  Forough L Nowrouzian; Olivier Clermont; Mona Edin; Anna Östblom; Erick Denamur; Agnes E Wold; Ingegerd Adlerberth
Journal:  Appl Environ Microbiol       Date:  2019-11-27       Impact factor: 4.792

6.  Inside the microbial and immune labyrinth: Gut microbes: friends or fiends?

Authors:  Warren Strober
Journal:  Nat Med       Date:  2010-11       Impact factor: 53.440

7.  Malassezia Is Associated with Crohn's Disease and Exacerbates Colitis in Mouse Models.

Authors:  Jose J Limon; Jie Tang; Dalin Li; Andrea J Wolf; Kathrin S Michelsen; Vince Funari; Matthew Gargus; Christopher Nguyen; Purnima Sharma; Viviana I Maymi; Iliyan D Iliev; Joseph H Skalski; Jordan Brown; Carol Landers; James Borneman; Jonathan Braun; Stephan R Targan; Dermot P B McGovern; David M Underhill
Journal:  Cell Host Microbe       Date:  2019-03-05       Impact factor: 21.023

Review 8.  Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

9.  Direct bacterial killing in vitro by recombinant Nod2 is compromised by Crohn's disease-associated mutations.

Authors:  Laurent-Herve Perez; Matt Butler; Tammy Creasey; JoAnn Dzink-Fox; John Gounarides; Stephanie Petit; Anna Ropenga; Neil Ryder; Kathryn Smith; Philip Smith; Scott J Parkinson
Journal:  PLoS One       Date:  2010-06-01       Impact factor: 3.240

10.  Systems biology analysis of gene expression during in vivo Mycobacterium avium paratuberculosis enteric colonization reveals role for immune tolerance.

Authors:  Sangeeta Khare; Sara D Lawhon; Kenneth L Drake; Jairo E S Nunes; Josely F Figueiredo; Carlos A Rossetti; Tamara Gull; Robin E Everts; Harris A Lewin; Cristi L Galindo; Harold R Garner; Leslie Garry Adams
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.